HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC Solicits Scientific Opinions On Dermal Sensitization QRA, Diethylene Glycol

This article was originally published in The Rose Sheet

Executive Summary

The European Commission is seeking a scientific perspective on the quantitative risk assessment (QRA) method introduced by the International Fragrance Association (IFRA) for assessing fragrance allergenicity

You may also be interested in...



Anti-Acne Toothpaste? FDA Warns VMV Hypoallergenics Maker For Claims Violations

The non-GRASE status of VHV Hypoallergenics' Essence Skin-Saving antiperspirant and toothpaste – promoted as effective on areas of the body other than underarms and preventative of acne-like rashes around the mouth, respectively – makes them unapproved drugs, FDA says.

SCCP Uncertain About Propyl & Butyl Parabens, Has Issues With IFRA’s QRA

Data is still insufficient for SCCP to render a final safety assessment for propyl and butyl parabens, the European Commission's Scientific Committee on Consumer Products says in a recently issued opinion

SCCP Uncertain About Propyl & Butyl Parabens, Has Issues With IFRA’s QRA

Data is still insufficient for SCCP to render a final safety assessment for propyl and butyl parabens, the European Commission's Scientific Committee on Consumer Products says in a recently issued opinion

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel